|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
26 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | Abstracts |
, |
2002 |
supplement-2 |
p. S57-S63 |
artikel |
||
| 2 | Abstracts |
, |
2002 |
supplement-2 |
p. S75-S78 |
artikel |
||
| 3 | A review of the European LeukemiaNet recommendations for the management of CML |
Baccarani, Michele |
2015 |
supplement-2 |
p. 141-147 |
artikel |
||
| 4 | Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients |
Hochhaus, Andreas |
2015 |
supplement-2 |
p. 133-140 |
artikel |
||
| 5 | Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU |
Conti, Rena M. |
2015 |
supplement-2 |
p. 249-257 |
artikel |
||
| 6 | CML—where do we stand in 2015? |
Hehlmann, Rüdiger |
2015 |
supplement-2 |
p. 103-105 |
artikel |
||
| 7 | Discontinuation of tyrosine kinase therapy in CML |
Mahon, Francois-Xavier |
2015 |
supplement-2 |
p. 187-193 |
artikel |
||
| 8 | Epidemiology of chronic myeloid leukaemia: an update |
Höglund, Martin |
2015 |
supplement-2 |
p. 241-247 |
artikel |
||
| 9 | Key Note and State of the Art Lectures |
, |
2002 |
supplement-2 |
p. S9-S19 |
artikel |
||
| 10 | Main Session I |
, |
2002 |
supplement-2 |
p. S26-S29 |
artikel |
||
| 11 | Main Session II |
, |
2002 |
supplement-2 |
p. S30-S37 |
artikel |
||
| 12 | Main Session III |
, |
2002 |
supplement-2 |
p. S38-S44 |
artikel |
||
| 13 | Main Sessions |
, |
2002 |
supplement-2 |
p. S67-S74 |
artikel |
||
| 14 | Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia |
Rea, Delphine |
2015 |
supplement-2 |
p. 149-158 |
artikel |
||
| 15 | Management of chronic myeloid leukemia in blast crisis |
Saußele, S. |
2015 |
supplement-2 |
p. 159-165 |
artikel |
||
| 16 | Managing pregnancy in chronic myeloid leukaemia |
Palani, Renuka |
2015 |
supplement-2 |
p. 167-176 |
artikel |
||
| 17 | Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization |
Cross, Nicholas C. P. |
2015 |
supplement-2 |
p. 219-225 |
artikel |
||
| 18 | Natural course and biology of CML |
Chereda, Bradley |
2015 |
supplement-2 |
p. 107-121 |
artikel |
||
| 19 | Perspectives: Plasticity of Stem Cells |
, |
2002 |
supplement-2 |
p. S20-S25 |
artikel |
||
| 20 | Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death |
Pfirrmann, Markus |
2015 |
supplement-2 |
p. 209-218 |
artikel |
||
| 21 | Pros and Cons Session: Indications for Allogeneic Transplants in Chronic Leukemias |
, |
2002 |
supplement-2 |
p. S45-S50 |
artikel |
||
| 22 | Response-related predictors of survival in CML |
Hanfstein, Benjamin |
2015 |
supplement-2 |
p. 227-239 |
artikel |
||
| 23 | Satelite Symposia |
, |
2002 |
supplement-2 |
p. S51-S56 |
artikel |
||
| 24 | The choice of first-line Chronic Myelogenous Leukemia treatment |
Fava, Carmen |
2015 |
supplement-2 |
p. 123-131 |
artikel |
||
| 25 | The interferon-alpha revival in CML |
Talpaz, Moshe |
2015 |
supplement-2 |
p. 195-207 |
artikel |
||
| 26 | The role of hematopoietic stem cell transplantation in chronic myeloid leukemia |
Gratwohl, Alois |
2015 |
supplement-2 |
p. 177-186 |
artikel |
26 gevonden resultaten